Sotorasib in KRASG12C mutated lung cancer

Lancet. 2024 Jan 13;403(10422):145. doi: 10.1016/S0140-6736(23)02035-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Mutation
  • Piperazines
  • Proto-Oncogene Proteins p21(ras)
  • Pyridines
  • Pyrimidines*

Substances

  • sotorasib
  • Proto-Oncogene Proteins p21(ras)
  • Piperazines
  • Pyridines
  • KRAS protein, human
  • Pyrimidines